Literature DB >> 20850178

Omsk haemorrhagic fever.

Daniel Růžek1, Valeriy V Yakimenko, Lyudmila S Karan, Sergey E Tkachev.   

Abstract

Omsk haemorrhagic fever is an acute viral disease prevalent in some regions of western Siberia in Russia. The symptoms of this disease include fever, headache, nausea, severe muscle pain, cough, and moderately severe haemorrhagic manifestations. A third of patients develop pneumonia, nephrosis, meningitis, or a combination of these complications. The only treatments available are for control of symptoms. No specific vaccine has been developed, although the vaccine against tick-borne encephalitis might provide a degree of protection against Omsk haemorrhagic fever virus. The virus is transmitted mainly by Dermacentor reticulatus ticks, but people are mainly infected after contact with infected muskrats (Ondatra zibethicus). Muskrats are very sensitive to Omsk haemorrhagic fever virus. The introduction of this species to Siberia in the 1930s probably led to viral emergence in this area, which had previously seemed free from the disease. Omsk haemorrhagic fever is, therefore, an example of a human disease that emerged owing to human-mediated disturbance of an ecological niche. We review the biological properties of the virus, and the epidemiological and clinical characteristics of Omsk haemorrhagic fever.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20850178     DOI: 10.1016/S0140-6736(10)61120-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  36 in total

1.  Tick-borne Encephalitis Vaccines.

Authors:  Axel T Lehrer; Michael R Holbrook
Journal:  J Bioterror Biodef       Date:  2011

2.  Simian hemorrhagic fever virus infection of rhesus macaques as a model of viral hemorrhagic fever: clinical characterization and risk factors for severe disease.

Authors:  Reed F Johnson; Lori E Dodd; Srikanth Yellayi; Wenjuan Gu; Jennifer A Cann; Catherine Jett; John G Bernbaum; Dan R Ragland; Marisa St Claire; Russell Byrum; Jason Paragas; Joseph E Blaney; Peter B Jahrling
Journal:  Virology       Date:  2011-10-19       Impact factor: 3.616

3.  Trans Complementation of Replication-defective Omsk Hemorrhagic Fever Virus for Antiviral Study.

Authors:  Qiuyan Zhang; Na Li; Chenglin Deng; Zherui Zhang; Xiaodan Li; Kentaro Yoshii; Hanqing Ye; Bo Zhang
Journal:  Virol Sin       Date:  2019-04-04       Impact factor: 4.327

4.  Inhibitors of tick-borne flavivirus reproduction from structure-based virtual screening.

Authors:  Dmitry I Osolodkin; Liubov I Kozlovskaya; Evgenia V Dueva; Victor V Dotsenko; Yulia V Rogova; Konstantin A Frolov; Sergey G Krivokolysko; Ekaterina G Romanova; Alexey S Morozov; Galina G Karganova; Vladimir A Palyulin; Vladimir M Pentkovski; Nikolay S Zefirov
Journal:  ACS Med Chem Lett       Date:  2013-07-30       Impact factor: 4.345

5.  Zika Virus Infection Associated With Severe Thrombocytopenia.

Authors:  Tyler M Sharp; Jorge Muñoz-Jordán; Janice Perez-Padilla; Melissa I Bello-Pagán; Aidsa Rivera; Daniel M Pastula; Jorge L Salinas; Jose H Martínez Mendez; Mónica Méndez; Ann M Powers; Stephen Waterman; Brenda Rivera-García
Journal:  Clin Infect Dis       Date:  2016-07-14       Impact factor: 9.079

6.  In vitro antiviral activity of adenosine analog NITD008 against tick-borne flaviviruses.

Authors:  Michael K Lo; Pei-Yong Shi; Yen-Liang Chen; Mike Flint; Christina F Spiropoulou
Journal:  Antiviral Res       Date:  2016-03-23       Impact factor: 5.970

Review 7.  Tick-Borne Flaviviruses, with a Focus on Powassan Virus.

Authors:  Gábor Kemenesi; Krisztián Bányai
Journal:  Clin Microbiol Rev       Date:  2018-12-12       Impact factor: 26.132

8.  A blood meal-induced Ixodes scapularis tick saliva serpin inhibits trypsin and thrombin, and interferes with platelet aggregation and blood clotting.

Authors:  Adriana M G Ibelli; Tae K Kim; Creston C Hill; Lauren A Lewis; Mariam Bakshi; Stephanie Miller; Lindsay Porter; Albert Mulenga
Journal:  Int J Parasitol       Date:  2014-02-28       Impact factor: 3.981

9.  A critical determinant of neurological disease associated with highly pathogenic tick-borne flavivirus in mice.

Authors:  Kentaro Yoshii; Yuji Sunden; Kana Yokozawa; Manabu Igarashi; Hiroaki Kariwa; Michael R Holbrook; Ikuo Takashima
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

Review 10.  Vaccines for viral hemorrhagic fevers--progress and shortcomings.

Authors:  Darryl Falzarano; Heinz Feldmann
Journal:  Curr Opin Virol       Date:  2013-06-15       Impact factor: 7.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.